SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Wegovy
Wegovy
Page 3 of 6
Finance
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By
Greg McKenna
October 7, 2024
Health
Ozempic may help manage opioid addiction: study
By
Naomi Kresge
and
Bloomberg
September 25, 2024
Health
Elon Musk and Bernie Sanders say they agree on one thing—cheaper Ozempic
By
Christiaan Hetzner
September 25, 2024
Politics
Bernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By
Madison Muller
,
Naomi Kresge
,
Riley Griffin
and
Bloomberg
September 24, 2024
Health
Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By
Ryan Hogg
September 24, 2024
Health
Roche stock is falling after report its Wegovy challenger is causing patients to vomit
By
Naomi Kresge
and
Bloomberg
September 12, 2024
Health
Wegovy reduced Covid deaths in obese patients, study finds
By
Madison Muller
and
Bloomberg
August 30, 2024
Retail
Secondhand luxury fashion thrives as Ozempic users purge their closets
By
Sasha Rogelberg
August 29, 2024
Retail
The Mars-Kellanova merger bolsters them against 2 big threats—inflation and Ozempic
By
Sasha Rogelberg
August 14, 2024
Health
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By
Alexa Mikhail
August 14, 2024
Health
Wegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits
By
Bloomberg
August 7, 2024
Health
How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices
By
Arthur Allen
and
KFF Health News
August 7, 2024
Commentary
I’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad
By
Angela Fitch
July 30, 2024
Finance
Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By
Prarthana Prakash
July 29, 2024
Health
The 5 biggest weight loss myths that ‘need to die,’ according to an obesity doctor
By
Lindsey Leake
July 18, 2024
Most Popular
Commentary
My wife sold her engagement ring to pay our tax bill. It led to my PhD and my career tackling the student-debt crisis
By
Brian Walsh
Success
Workday’s CEO says his career took off after he changed his attitude—and Amazon boss Andy Jassy swears by the same...
By
Preston Fore
Success
AI expert says it’s ‘not a question’ that AI will take over all jobs—but people will have 80 hours a week of free time
By
Emma Burleigh